Effectiveness of Triamcinolone Acetonide to surppress inflammation after eyelid surgery

Effectiveness of Triamcinolone Acetonide to surppress inflammation after eyelid surgery - Triamcinolone Acetonide for eyelid surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032760

Enrollment

Registered

2018-05-30

Start date

2018-05-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blepharoptosis

Interventions

Inject Triamcinolone Acetonide into orbicularis oculi muscle at the end of the surgery Not to Inject Triamcinolone Acetonide into orbicularis oculi muscle at the end of the surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient who needs both blepharoptosis repair simultaneously

Exclusion criteria

Exclusion criteria: Ongoing infection, steroid resopnder, Glaucoma, Uncontrolled Diabetes, history of trauma or surgery on face

Design outcomes

Primary

Measure	Time frame
Questionnaire to evaluate the inflammation result Upper Margin-Refrex distance Levator function	—

Secondary

Measure	Time frame
complications	—

Countries

Japan

Contacts

Public ContactMimura Masashi

Osaka Medical College Ophthalmology

opt119@osaka-med.ac.jp0726831221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026